Latest Breaking News On - Globe newswire gt biopharma inc - Page 2 : comparemela.com

GT Biopharma, Inc Announces 1-for-30 Reverse Stock Split

GT Biopharma, Inc Announces 1-for-30 Reverse Stock Split
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesCorey davisCompany board of directorsGlobe newswire gt biopharma incSource gt biopharma incComputershare trust companyUniversity of minnesotaCompany special meeting of stockholdersExchange commissionCompany boardComputershare incGt biopharma incNasdaq capital marketMinimum bid price requirementNasdaq capitalSpecial meeting

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote FOR All Proposed Items at the Upcoming Special Meeting of Stockholders

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote FOR All Proposed Items at the Upcoming Special Meeting of Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCorey davisMichael breenGlass lewis coGlobe newswire gt biopharma incGt biopharma incExchange commission onInstitutional shareholder services incUniversity of minnesotaCompany board of directors theSaratoga proxy consultingExchange commissionInstitutional shareholder servicesGlass lewisNasdaq capital marketExecutive chairman

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesCorey davisMichael breenDrug administrationGt biopharma incExchange commissionGlobe newswire gt biopharma incUniversity of minnesotaInvestigational new drugExecutive chairmanInterim chief executiveRelations contact

GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJeff millerCorey davisJeffrey millerMartin felicesUniversity of minnesotaSociety for immunotherapy of cancerExchange commissionGlobe newswire gt biopharma incGt biopharma incPresented positive preclinical dataTargeted prostate cancer treatment duringAssociate professorAnnual meetingCalifornia november

GT Biopharma, Inc : GT Biopharma Reports Second Quarter 2023 Financial Results

GT Biopharma, Inc : GT Biopharma Reports Second Quarter 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMichael breenCorey davisDrug administrationGlobe newswire gt biopharma incDevelopment rd expensesGt biopharma incExchange commissionUniversity of minnesotaExecutive chairmanChief executiveRelations contactLoss per shareAverage common shares outstandingThree months ended juneSix months ended june